Joanne Kim Biography and Net Worth

CFO of BioVie

Presently, Joanne Wendy Kim occupies the position of Chief Financial Officer & Secretary at BioVie, Inc.

In her past career she occupied the position of Chief Financial Officer for Landmark Education Enterprises, Inc., Senior Manager at KPMG LLP and Director-National Office Sec Department at BDO USA LLP.

She received an undergraduate degree from The California State University.

What is Joanne Wendy Kim's net worth?: The estimated net worth of Joanne Wendy Kim is at least $4.52 thousand as of August 28th, 2026. Ms. Kim owns 3,441 shares of BioVie stock worth more than $4,525 as of October 8th. This net worth evaluation does not reflect any other assets that Ms. Kim may own. Learn More about Joanne Wendy Kim's net worth.
How do I contact Joanne Wendy Kim?: The corporate mailing address for Ms. Kim and other BioVie executives is 680 W Nye Lane, Suite 201, Carson City, NV, 89703. BioVie can also be reached via phone at (775) 888-3162 and via email at [email protected]. Learn More on Joanne Wendy Kim's contact information.
Has Joanne Wendy Kim been buying or selling shares of BioVie?: Joanne Wendy Kim has not been actively trading shares of BioVie in the last ninety days. Most recently, on Friday, August 28th, Joanne Wendy Kim bought 2,500 shares of BioVie stock. The stock was acquired at an average cost of $2.18 per share, with a total value of $5,450.00. Following the completion of the transaction, the chief financial officer now directly owns 3,441 shares of the company's stock, valued at $7,501.38. Learn More on Joanne Wendy Kim's trading history.
Who are BioVie's active insiders?: BioVie's insider roster includes Amy Chappell (Director), Cuong Do (President & Chief Executive Officer), Joanne Kim (CFO), and Joseph Palumbo (Executive Vice President, Research & Development and Chief Medical Officer). Learn More on BioVie's active insiders.
Are insiders buying or selling shares of BioVie?: During the last twelve months, BioVie insiders bought shares 4 times. They purchased a total of 23,280 shares worth more than $49,118.00. The most recent insider tranaction occured on August, 28th when insider Joseph M. Palumbo bought 4,843 shares worth more than $10,460.88. Insiders at BioVie own 16.7% of the company. Learn More about insider trades at BioVie.
Information on this page was last updated on 8/28/2026.

Joanne Wendy Kim Insider Trading History at BioVie

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/28/2026	Buy	2,500	$2.18	$5,450.00	3,441
12/7/2021	Buy	200	$54.00	$10,800.00

Joanne Wendy Kim Buying and Selling Activity at BioVie

BioVie Company Overview

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Today's Range

Now: $1.32

$1.30

$1.39

50 Day Range

MA: $1.70

$0.96

$2.28

2 Week Range

Now: $1.32

$0.82

$3.79

Volume

260,536 shs

Average Volume

1,599,458 shs

Market Capitalization

$11.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73